Us Physicalrapy Stock Performance
| USPH Stock | USD 78.72 0.22 0.28% |
US Physicalrapy has a performance score of 1 on a scale of 0 to 100. The entity owns a Beta (Systematic Risk) of 1.37, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, US Physicalrapy will likely underperform. US Physicalrapy at this moment owns a risk of 2.33%. Please validate US Physicalrapy coefficient of variation, semi variance, period momentum indicator, as well as the relationship between the treynor ratio and daily balance of power , to decide if US Physicalrapy will be following its current price history.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in US Physicalrapy are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, US Physicalrapy is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
Actual Historical Performance (%)
One Day Return 0.28 | Five Day Return (2.57) | Year To Date Return (10.42) | Ten Year Return 52.53 | All Time Return 4 K |
Forward Dividend Yield 0.0229 | Payout Ratio | Last Split Factor 3:2 | Forward Dividend Rate 1.8 | Dividend Date 2025-12-12 |
1 | Does Recent Industry Consolidation Signal Opportunity in U.S. Physical Therapy Stock for 2025 | 10/30/2025 |
2 | U.S. Physical Therapy declares 0.45 dividend | 11/07/2025 |
3 | U.S. Physical Therapy Exploring Valuation After Recent Share Price Decline | 11/12/2025 |
4 | Disposition of 743 shares by Graham Reeve of US Physicalrapy at 71.01 subject to Rule 16b-3 | 11/24/2025 |
5 | Independent Director of U.S. Physical Therapy Picks Up 19 percent More Stock | 11/26/2025 |
6 | Is U.S. Physical Therapys Recent Rebound Enough to Justify Its Valuation Reset | 12/09/2025 |
7 | U.S. Physical Therapy, Inc. Given Average Recommendation of Moderate Buy by Analysts | 12/10/2025 |
| US Physicalrapy dividend paid on 12th of December 2025 | 12/12/2025 |
8 | As U.S. Physical Therapy advances 6.4 percent this past week, investors may now be noticing the companys five-year earnings growth | 12/16/2025 |
| Begin Period Cash Flow | 152.8 M | |
| Total Cashflows From Investing Activities | -149.4 M |
US Physicalrapy Relative Risk vs. Return Landscape
If you would invest 7,799 in US Physicalrapy on September 19, 2025 and sell it today you would earn a total of 73.00 from holding US Physicalrapy or generate 0.94% return on investment over 90 days. US Physicalrapy is currently generating 0.0424% in daily expected returns and assumes 2.3263% risk (volatility on return distribution) over the 90 days horizon. In different words, 20% of stocks are less volatile than USPH, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
US Physicalrapy Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for US Physicalrapy's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as US Physicalrapy, and traders can use it to determine the average amount a US Physicalrapy's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0182
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | USPH |
Based on monthly moving average US Physicalrapy is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of US Physicalrapy by adding it to a well-diversified portfolio.
US Physicalrapy Fundamentals Growth
USPH Stock prices reflect investors' perceptions of the future prospects and financial health of US Physicalrapy, and US Physicalrapy fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on USPH Stock performance.
| Return On Equity | 0.0844 | ||||
| Return On Asset | 0.0426 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 1.47 B | ||||
| Shares Outstanding | 15.2 M | ||||
| Price To Earning | 34.35 X | ||||
| Price To Book | 2.45 X | ||||
| Price To Sales | 1.59 X | ||||
| Revenue | 671.35 M | ||||
| Gross Profit | 164.91 M | ||||
| EBITDA | 86.91 M | ||||
| Net Income | 45.6 M | ||||
| Cash And Equivalents | 48.57 M | ||||
| Cash Per Share | 3.73 X | ||||
| Total Debt | 295.23 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 1.43 X | ||||
| Book Value Per Share | 33.12 X | ||||
| Cash Flow From Operations | 74.94 M | ||||
| Earnings Per Share | 2.37 X | ||||
| Market Capitalization | 1.19 B | ||||
| Total Asset | 1.17 B | ||||
| Retained Earnings | 227.26 M | ||||
| Working Capital | 21.3 M | ||||
| Current Asset | 60.18 M | ||||
| Current Liabilities | 19.01 M | ||||
About US Physicalrapy Performance
By evaluating US Physicalrapy's fundamental ratios, stakeholders can gain valuable insights into US Physicalrapy's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if US Physicalrapy has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if US Physicalrapy has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (2.13) | (2.23) | |
| Return On Tangible Assets | 0.08 | 0.12 | |
| Return On Capital Employed | 0.06 | 0.06 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.05 | 0.08 |
Things to note about US Physicalrapy performance evaluation
Checking the ongoing alerts about US Physicalrapy for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for US Physicalrapy help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 98.0% of the company outstanding shares are owned by institutional investors | |
| On 12th of December 2025 US Physicalrapy paid $ 0.45 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: As U.S. Physical Therapy advances 6.4 percent this past week, investors may now be noticing the companys five-year earnings growth |
- Analyzing US Physicalrapy's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether US Physicalrapy's stock is overvalued or undervalued compared to its peers.
- Examining US Physicalrapy's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating US Physicalrapy's management team can have a significant impact on its success or failure. Reviewing the track record and experience of US Physicalrapy's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of US Physicalrapy's stock. These opinions can provide insight into US Physicalrapy's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for USPH Stock analysis
When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |